GLP-1 Receptor Agonist Clinical Evidence for Weight Management
GLP-1 weight loss and body image concerns are increasingly relevant for family medicine clinicians prescribing receptor agonists like semaglutide. Patients often enter treatment with preexisting body image disturbances that rapid weight loss and shifting…
Endocannabinoid System Research: Adolescent Eating & Mental Health
Adolescent eating disorders mental health research highlights lasting effects on early adulthood mental health and substance use. This 15-year Canadian cohort study identifies key risk and protective factors. Clinicians should prioritize early screening…
Endocannabinoid System Clinical Research: REAL 2.0 Findings
The REAL 2.0 study highlights endocannabinoid system adolescent mental health factors influencing adult outcomes. Early body image and disordered eating patterns are key indicators. This research supports early screening for mental health and substance…
Endocannabinoid System Clinical Research: Eating Disorders
This article covers endocannabinoid system adolescent eating disorder research focusing on how adolescent risk factors contribute to eating disorders. The study highlights the importance of early screening for disordered eating and body image concerns.…
Endocannabinoid System & Adolescent Weight Research 2026
This 2026 study examines adolescent weight-related pathology and its impact on mental health and substance use outcomes. The research highlights how body image concerns and disordered eating in adolescence affect adult health. Findings emphasize the role…
Endocannabinoid System Clinical Research: REAL 2.0 Study Overview
The endocannabinoid system adolescent mental health research from the REAL 2.0 study tracks youth over 15 years to understand eating disorders and substance use. This research highlights how adolescent body image and disordered eating predict adult…